Literature DB >> 28738439

Terpenoids from the Oleo-Gum-Resin of Boswellia serrata and Their Antiplasmodial Effects In Vitro.

Hippolyt L Greve1, Marcel Kaiser2,3, Reto Brun2,3, Thomas J Schmidt1.   

Abstract

In the course of our ongoing search for new natural products as leads against protozoal diseases, the dichloromethane extract of Indian frankincense, the oleo-gum-resin obtained from Boswellia serrata, showed in vitro activity against Plasmodium falciparum. Bioactivity-guided fractionation led to the isolation of eight diterpenes: (1S,3E,7E,11R)-verticilla-3,7,12(18)-triene (1), cembrene A (2), serratol (3), 1S,3E,7R,8R,11E-7,8-epoxy-cembra-3,11-dien-1-ol (4), incensole oxide (5), rel (1S,3R,7E,11S,12R)-1,12-epoxy-4-methylenecembr-7-ene-3, 11-diol (6), isoincensole oxide (7), and isodecaryiol (8). Furthermore, 10 triterpenes, namely, oleanolic acid (9), 11-keto-β-boswellic acid (10), 3-epi-neoilexonol (11), uvaol (12), β-boswellic aldehyde (13), 5α-tirucalla-8,24-dien-3α-ol (14), isoflindissone lactone (15), isoflindissol lactone (16), rel (8R,9S,20R)-tirucall-24-ene-3β,20-diol (17), and rel (3α,8R, 9S,20R,24S)-20,24-epoxytirucalla-3,25-diol (18) as well as the sesquiterpene β-bourbonene (19), the monoterpene carvacrol (20) and the phenyl propanoids methyleugenol (21), and p-methoxycinnamaldehyde (22) were isolated. All compounds were identified by mass spectrometry and nuclear magnetic resonance spectroscopic measurements. Compounds 6, 11, and 16-18 are described for the first time. Compounds 13 - 15 are isolated as natural products for the first time, compound 8 for the first time from a plant. Antiplasmodial IC50 values and cytotoxicity against L6 rat skeletal myoblasts were determined. Isoflindissone lactone (15) was the most active compound with an IC50 of 2.2 µM against P. falciparum and a selectivity index of 18. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28738439     DOI: 10.1055/s-0043-116943

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

Review 1.  Antiplasmodial natural products: an update.

Authors:  Nasir Tajuddeen; Fanie R Van Heerden
Journal:  Malar J       Date:  2019-12-05       Impact factor: 2.979

2.  Triterpenic Acids as Non-Competitive α-Glucosidase Inhibitors from Boswellia elongata with Structure-Activity Relationship: In Vitro and In Silico Studies.

Authors:  Najeeb Ur Rehman; Sobia Ahsan Halim; Mohammed Al-Azri; Majid Khan; Ajmal Khan; Kashif Rafiq; Ahmed Al-Rawahi; Rene Csuk; Ahmed Al-Harrasi
Journal:  Biomolecules       Date:  2020-05-12

3.  Chemical, molecular and structural studies of Boswellia species: β-Boswellic Aldehyde and 3-epi-11β-Dihydroxy BA as precursors in biosynthesis of boswellic acids.

Authors:  Ahmed Al-Harrasi; Najeeb Ur Rehman; Abdul Latif Khan; Muhammed Al-Broumi; Issa Al-Amri; Javid Hussain; Hidayat Hussain; René Csuk
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

4.  Machine Learning Analysis of Essential Oils from Cuban Plants: Potential Activity against Protozoa Parasites.

Authors:  Renata Priscila Barros de Menezes; Luciana Scotti; Marcus Tullius Scotti; Jesús García; Rosalia González; Lianet Monzote; William N Setzer
Journal:  Molecules       Date:  2022-02-17       Impact factor: 4.411

Review 5.  Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2.

Authors:  Zahra Jamshidi; Maryam Hashemi; Rezvan Yazdian-Robati; Leila Etemad; Zahra Salmasi; Prashant Kesharwani
Journal:  Inflammopharmacology       Date:  2022-07-26       Impact factor: 5.093

6.  Boswellic Acids Show In Vitro Activity against Leishmania donovani.

Authors:  Hippolyt L Greve; Marcel Kaiser; Pascal Mäser; Thomas J Schmidt
Journal:  Molecules       Date:  2021-06-15       Impact factor: 4.411

Review 7.  Biological Activity of Selected Natural and Synthetic Terpenoid Lactones.

Authors:  Alicja K Surowiak; Lucyna Balcerzak; Stanisław Lochyński; Daniel J Strub
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.